Matthew K. Abramowitz

Matthew K. Abramowitz is a Professor of Medicine (Nephrology) at Albert Einstein College of Medicine and a practicing nephrologist at Montefiore Medical Center. He completed his medical education at Einstein, residency at Montefiore, and nephrology fellowship at Einstein/Montefiore, earning a Master’s in Clinical Research. His research focuses on mechanisms of physical dysfunction in chronic kidney disease (CKD), including skeletal muscle pathology, metabolic acidosis, and gait disturbances. He holds roles as Scientific Director of Einstein’s Clinical Research Center and Montefiore Einstein Cancer Center’s Biorepository.

Education:

• Medical Education: Albert Einstein College of Medicine
• Internal Medicine Residency: Montefiore Medical Center (Chief Resident)
• Nephrology Fellowship: Einstein/Montefiore
• Master’s in Clinical Research: Einstein’s Clinical Research Training Program

Research Interests: His work employs wearable technologies, metabolic studies, and tissue biopsies to investigate CKD-linked impaired physical function. Key themes include skeletal muscle fibrosis, gait abnormalities, metabolic acidosis, and accelerated aging. He has pioneered studies on serum bicarbonate’s role in CKD progression and mortality.

Publications: Recent work includes studies on obesity’s link to low bicarbonate, cognitive-motor interference in CKD, and skeletal muscle fibrosis. His research bridges clinical and translational approaches to improve CKD patient outcomes.

Awards:

• Carl Gottschalk Research Scholar Grant (American Society of Nephrology)
• Einstein/Montefiore Career Development Award
• NIH K23 and R01 Awards

Labs/Teams: Directs Einstein’s Clinical Research Center and Advanced Biomarker Core. Leads studies on CKD pathophysiology and clinical trial design for metabolic interventions.